IG Clinical Trial Report Stresses Commercial Pressure To Speed Enrollment
This article was originally published in The Tan Sheet
The commercial pressures to hasten clinical trial enrollment could be ripe for legislative attention in the context of consideration of bills to improve IRBs.
You may also be interested in...
FDA clinical site inspections should focus on recruitment tactics as well as data integrity, the HHS Office of the Inspector General suggests in a report on clinical trial recruitment released June 12.
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Perrigo promotes in pricing, planning